Exelon establishes $2.5B at-the-market equity offering program

EXELON CORP

May sell up to $2.5B aggregate gross sales price of common stock via sales agents and forward sellers.
Agreement dated May 2, 2025; underwriters include Barclays, BofA, Citi, Goldman Sachs, J.P. Morgan, Morgan Stanley, and others.
Company may also enter forward sale agreements; proceeds expected for general corporate purposes, including debt repayment.
No obligation to sell; sales may be suspended or terminated at any time.
Program registered under Form S-3 (No. 333-284911); legal opinion filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.